Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

SRx Health Solutions (SRXH) EBITDA Margin: 2010-2024

Historic EBITDA Margin for SRx Health Solutions (SRXH) over the last 10 years, with FY2024 value amounting to 32.73%.

  • SRx Health Solutions' EBITDA Margin fell 2487700.0% to 235.21% in Q2 2025 from the same period last year, while for Jun 2025 it was 137.81%, marking a year-over-year decrease of 1204900.0%. This contributed to the annual value of 32.73% for FY2024, which is 876100.0% up from last year.
  • Per SRx Health Solutions' latest filing, its EBITDA Margin stood at 32.73% for FY2024, which was up 876100.0% from 54.88% recorded in FY2023.
  • In the past 5 years, SRx Health Solutions' EBITDA Margin registered a high of 32.73% during FY2024, and its lowest value of 70.95% during FY2022.
  • In the last 5 years, SRx Health Solutions' EBITDA Margin had a median value of 54.88% in 2023 and averaged 38.96%.
  • Per our database at Business Quant, SRx Health Solutions' EBITDA Margin skyrocketed by 1690500bps in 2020 and then crashed by -334000bps in 2022.
  • Over the past 5 years, SRx Health Solutions' EBITDA Margin (Annual) stood at 64.15% in 2020, then surged by 41bps to 37.56% in 2021, then plummeted by -89bps to 70.95% in 2022, then increased by 23bps to 54.88% in 2023, then surged by 160bps to 32.73% in 2024.
  • Its EBITDA Margin stands at 32.73% for FY2024, versus 54.88% for FY2023 and 70.95% for FY2022.